Literature DB >> 12107670

Definitions and methods of cost assessment: an intensivist's guide. ESICM section on health research and outcome working group on cost effectiveness.

M Jegers1, D L Edbrooke, C L Hibbert, D B Chalfin, H Burchardi.   

Abstract

OBJECTIVE: To define the different types of costs incurred in the care of critically ill patients and to describe some of the most commonly used methods for measuring and allocating these costs.
DESIGN: Literature review. Definitions for opportunity, direct and indirect, fixed, variable, marginal, and total costs are described and interpreted in the context of the critical care setting. Two main methods of costing are described: the 'top-down' and 'bottom-up' methods together with a number of cost proxies, such as the use of weighted hospital days, diagnosis-related groups, severity and activity scores, and effective costs per survivor.
CONCLUSIONS: The assessment and allocation of costs to critically ill patients is complex and as a result of the different definitions and methods used, meaningful comparisons between studies are plagued with difficulty. When undertaking a study looking to measure costs, it is important to state: (a) the aim of the cost assessment study; (b) the perspective (point of view); (c) the type of costs that need to be measured; and (d) the time span of assessment. By being explicit about the rationale of the study and the methods used, it is hoped that the results of economic evaluations will be better understood, and hence implemented within the critical care setting.

Entities:  

Mesh:

Year:  2002        PMID: 12107670     DOI: 10.1007/s00134-002-1279-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  19 in total

1.  Understanding Costs When Seeking Value in Critical Care.

Authors:  Meeta Prasad Kerlin; Colin R Cooke
Journal:  Ann Am Thorac Soc       Date:  2015-12

Review 2.  [Necessity and problems with case-related costing for intensive care patients].

Authors:  M Weiss; J Martin; U Feser; C Schafmayer; M Bauer
Journal:  Anaesthesist       Date:  2005-03       Impact factor: 1.041

3.  Cost awareness of physicians in intensive care units: a multicentric national study.

Authors:  Romain Hernu; Martin Cour; Sylvie de la Salle; Dominique Robert; Laurent Argaud
Journal:  Intensive Care Med       Date:  2015-05-22       Impact factor: 17.440

Review 4.  [The cost of sepsis].

Authors:  O Moerer; H Burchardi
Journal:  Anaesthesist       Date:  2006-06       Impact factor: 1.041

5.  Variable costs of ICU patients: a multicenter prospective study.

Authors:  Carlotta Rossi; Bruno Simini; Luca Brazzi; Giancarlo Rossi; Danilo Radrizzani; Gaetano Iapichino; Guido Bertolini
Journal:  Intensive Care Med       Date:  2006-02-25       Impact factor: 17.440

6.  Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach.

Authors:  Michelle R Ananda-Rajah; Allen Cheng; C Orla Morrissey; Tim Spelman; Michael Dooley; A Munro Neville; Monica Slavin
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

7.  Cost-effectiveness of the Surviving Sepsis Campaign protocol for severe sepsis: a prospective nation-wide study in Spain.

Authors:  David Suarez; Ricard Ferrer; Antonio Artigas; Izaskun Azkarate; José Garnacho-Montero; Gemma Gomà; Mitchell M Levy; Juan Carlos Ruiz
Journal:  Intensive Care Med       Date:  2010-12-09       Impact factor: 17.440

8.  One-year mortality, quality of life and predicted life-time cost-utility in critically ill patients with acute respiratory failure.

Authors:  Rita Linko; Raili Suojaranta-Ylinen; Sari Karlsson; Esko Ruokonen; Tero Varpula; Ville Pettilä
Journal:  Crit Care       Date:  2010-04-12       Impact factor: 9.097

9.  A multicentre, prospective study to evaluate costs of septic patients in Brazilian intensive care units.

Authors:  Ana M C Sogayar; Flavia R Machado; Alvaro Rea-Neto; Amselmo Dornas; Cintia M C Grion; Suzana M A Lobo; Bernardo R Tura; Carla L O Silva; Ruy G R Cal; Idal Beer; Vilto Michels; Jorge Safi; Marcia Kayath; Eliezer Silva
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 10.  Cost and health care utilization in ARDS--different from other critical illness?

Authors:  Thomas Bice; Christopher E Cox; Shannon S Carson
Journal:  Semin Respir Crit Care Med       Date:  2013-08-11       Impact factor: 3.119

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.